The rise of DOLs doesn’t mean pharma should upend KOL approach.
Read Roberts
Advertisement
Director, KOL Data Solutions, PRECISIONscientia
Articles by Read Roberts
Advertisement
Latest Updated Articles
Food for Thought: Make Room for Multiple OpinionsPublished: March 10th 2023 | Updated: